Impact of Oral Magnesium on Neuropathic Pain

• Status: Completed
• Trial end date: 2008-06-01
• Target enrollment: 0
• Participant gender: All

Summary

Use lay language.

The aim of this study is to evaluate on pain scores (neuropathic pain questionnaire and pain numeric scale) and on quality of life, the effect of oral magnesium intake on patients with neuropathic pain comparing with patients receiving placebo,. The study drug will be taken during 4 weeks.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Clermont-Ferrand

Criteria

Inclusion Criteria:

• neuropathic pain

• informed signed consent

Exclusion Criteria:

• magnesium intake contra-indication

• severe renal insufficiency

• quinidine intake

• concomitant treatment change 2weeks before inclusion

• evolutive pathology